GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Clarification sought from Genesys International Corporation Ltd
The Exchange has sought clarification from Genesys International Corporation Ltd on December 03, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2020 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of Related Party Transactions on a consolidated basis drawn in accordance with applicable accounting standards for the half year ended September 30, 2020. We request you to take the same on your record. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Un-audited financial results for the second quarter and half year ended September 30, 2020. We are enclosing herewith the copy of Un-audited standalone and consolidated financial results of the Company for the second quarter and half year ended September 30, 2020 as published in the newspaper - The Free Press Journal (English) and Navshakti (Marathi). GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Compensation Committee at its meeting held on November 03, 2020 has approved the allotment of 82,000 equity shares of face value of Rs. 5.00 each pursuant to the exercise of the Stock Options by the eligible employees of the company under the Genesys ESOP Scheme -2010. Consequently, post-allotment the paid-up capital of the company shall stand increased to Rs. 15,61,28,560/- divided into 3,12,25,712 Equity Shares of face value of Rs. 5.00 each. These shares shall rank pari passu with the existing equity shares of the Company in all respects. You are requested to take the above on your record. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Results- Financial Results For Quarter And Half Year Ended September 30, 2020.
In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today on November 03, 2020 has inter alia approved the Un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2020. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2020. ii. Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of the Board commenced at 04:30 pm and concluded at 05.30 PM You are requested to take the above on your records. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Outcome Of Board Meeting Held On November 03, 2020
In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today on November 03, 2020 has inter alia approved the Un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2020. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2020. ii. Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of the Board commenced at 04:30 pm and concluded at 05.30 PM GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copy of Newspaper publication in respect of notice of Board Meeting of the Company published in The Free Press Journal (English) and Navshakti (Marathi) Newspapers. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Intimation Of Board Meeting To Approve The Un Audited Financial Results For The Second Quarter Ended September 30, 2020.
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, November 03, 2020, inter alia , to consider and approve the un-audited (standalone and consolidated) financial results of the Company for the second quarter ended September 30, 2020. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Filing Of Compliance Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half -Year Ended September 30, 2020
Pursuant to Regulation 40(9) read with Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Compliance Certificate for the half-year ended on September 30, 2020 issued by Roy Jacob & Co., Company Secretaries, the copy of which will be placed before the ensuing meeting of the Board of Directors of the Company. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith the Certificate received from M/s. Bigshare Services Private Limited the Registrar and share Transfer Agent of the Company for the quarter ended September 30, 2020.